JBIO
Jade Biosciences, Inc.
+0.51 (+3.06%)17.16USD318K成交股數1.1B市值2.0本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 50.1M | 36.1M | 22.0M | 22.5M | 20.0M | 19.4M | 13.6M | 78K | 20.1M | 16.9M | 16.0M | 13.5M |
| 銷售管理費用 | 8.9M | 7.4M | 5.4M | 5.2M | 3.4M | 15.0M | 1.4M | 512K | 4.5M | 4.5M | 4.3M | 4.2M |
| 營業利益 | −58.9M+152% | −43.4M+28% | −27.4M+76% | −27.8M+4608% | −23.4M-5% | −33.8M+58% | −15.6M-24% | −590K-97% | −24.6M | −21.4M | −20.3M | −17.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −55.8M+46% | −40.4M+36% | −25.2M+55% | −32.1M+5346% | −38.2M+65% | −29.6M+51% | −16.3M-14% | −590K-96% | −23.2M | −19.6M | −19.0M | −16.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.76-94% | -0.57-115% | -0.48-91% | -0.86+353% | -12.10+1358% | 3.74-627% | -5.16+579% | -0.19-72% | -0.83 | -0.71 | -0.76 | -0.67 |
| 稀釋股數 | 61.1M | 57.8M | 39.6M | 28.4M | 3.2M | 28.6M | 3.2M | 3.2M | 27.8M | 27.6M | 25.2M | 24.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 107M | 55.1M | 50.1M | 221M | 44.2M | 69.4M | 31.1M | 31.1M | 9.1M | 32.2M | 60.9M | 26.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 472M | 319M | 202M | 224M | 77.5M | 72.8M | 91.0M | 112M | 107M | 141M | 156M | 124M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 32.2M | 23.0M | 23.1M | 22.4M | 2.5M | 120M | 10.5M | 17.3M | 15.9M | 15.2M | 13.8M | 11.3M |
| 股東權益 | 440M | 296M | 179M | 202M | −83.5M | −46.8M | −16.9M | −589K | 90.9M | 126M | 142M | 113M |
| 負債比 | 6.8% | 7.2% | 11.4% | 10.0% | 3.2% | 164.3% | 11.5% | 15.5% | 14.9% | 10.8% | 8.9% | 9.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −24.1M-41% | – | – | −18.8M-21% | −40.7M | −6.8M | 0.00-100% | −23.7M | – | – | −11.4M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 16K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −11.4M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −127M | –% | -3.19 | −94.9M |
| FY2024 | – | – | −69.6M | –% | -2.44 | – |
| FY2023 | – | – | −75.5M | –% | -2.87 | −56.9M |
| FY2022 | – | – | −51.5M | –% | -2.10 | −39.3M |
| FY2021 | – | – | −23.0M | –% | -1.87 | −27.6M |
| FY2020 | – | – | −9.6M | –% | -40.31 | – |